This Registration Ensures SoHum Products are Compliant With all
California Regulations for Organic Materials
Lakewood, CO -- December 14, 2022 -- InvestorsHub
NewsWire -- American Cannabis Company, Inc. (OTCQB:
AMMJ) (“ACC” or “Company”), a business-to-business cannabis
consulting solutions provider and licensed owner operator, is
pleased to announce that our subsidiary company SoHum Living Soils® has received Organic
Input Material (OIM) certification from the California Department
of Food and Agriculture. This certification ensures that SoHum
products are compliant with all California regulations for organic
materials, and it establishes SoHum as a premium living soil
product.
“We’re extremely excited about receiving this certification.
SoHum Living Soils® is dedicated to clean green organic
cultivation, and compliance with California’s OIM Program is
another recognition that SoHum products deliver the finest quality
organic materials available,” said Ellis Smith, chairman and
founder of American Cannabis Company.
The Organic Input
Material (OIM) Program registers fertilizing materials to
be used in organic crop and food production. OIM registered
products must be verified to comply with the California Fertilizing
Materials Law and Regulations and USDA National Organic Program
Standards.
As part of this certification, SoHum products have been
registered with the Fertilizing Materials Inspection Program
(FMIP), an industry-funded program ensuring consumers receive
materials that adhere to the quality and quantity guaranteed on the
product label. FMIP products undergo routine sampling and
inspections to ensure these standards are maintained over time.
SoHum Living Soils® now has triple certification. In 2021, they
received Organic Materials Review Institute (OMRI) and Clean Green
Certification. OMRI is an international nonprofit organization that
reviews and approves products for use in organic production and
processing. The Clean Green Certification Program provides a
process to hold cannabis products to the same high standards
associated with organic growing that are applied to produce. Very
few soil products have all three certifications.
About American Cannabis Company, Inc.
American Cannabis Company, Inc. offers clean green solutions to
existing and aspiring participants in the cannabis and hemp
industries. We utilize our industry expertise to provide business
planning and market assessment services, assist state licensing
procurement, create business infrastructure and operational best
practices. The Company currently owns and operates Naturaleaf in
Colorado Springs, Colorado. This medically licensed entity consists
of three (3) retail dispensaries, one (1) commercial cultivation
facility, and one (1) non-volatile extraction operation. American
Cannabis Company has also developed SoHum Living Soils® – Winner of
the High Times S.T.A.S.H. Award for “Best Potting Mix”, OMRI
Listed®, and Clean Green Certified®.
For more information about American Cannabis Company, please
visit:
www.theacclife.com
www.sohumsoils.com
www.thenaturaleaf.com
Video Links:
https://americancannabisconsulting.com/resources/video/
(ACC Site)
(SoHum Living Soils®)
ACC Contact:
IR@americancannabisconsulting.com
Forward-Looking Statements
This news release contains "forward-looking statements," which
are not purely historical and may include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan". These or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based drugs. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements or to
update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-K for the most recent
fiscal year, our quarterly reports on Form 10-Q and other periodic
reports filed from time to time with the Securities and Exchange
Commission. For more information, please visit www.sec.gov.
Cannabis Remains an Illegal Schedule 1 Drug Under
Federal Law
Thirty-five states, including Colorado, the District of Columbia
and four U.S. Territories currently have laws broadly legalizing
cannabis in some form for either medicinal and/or recreational use
governed by state specific laws and regulations. Although legalized
in some states, cannabis is a “Schedule 1” drug under the
Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal
under federal law. Cannabis and its derivatives are viewed as being
highly addictive and having no medical value. The United States
Drug Enforcement Agency enforces the Controlled Substances Act, and
persons violating it are subject to federal criminal
prosecution.
As a result of the November 2020 federal elections, and the
election of Joseph R. Biden as president, it is expected that the
federal government will move to amend parts of the
CSA and deschedule cannabis as a Schedule 1 drug.
In late January, 2021, Senate Majority Leader Chuck Schumer said
lawmakers are in the process of merging various cannabis bills,
including his own legalization legislation. He is working to enact
reform in this Congressional session. This would include the
Marijuana Freedom and Opportunity Act, that would federally
de-schedule cannabis, reinvest tax revenue into communities most
affected by the drug war, and fund efforts to expunge prior
cannabis records. It is likely that the Marijuana Opportunity,
Reinvestment, and Expungement (MORE) Act would be incorporated.
Other federal legislation under review for possible submission
includes the SAFE Banking Act (or Secure and Fair Enforcement Act),
a bill that would allow cannabis companies to access the
federally-insured banking system and capital markets without the
risk of federal enforcement action, and the Strengthening the Tenth
Amendment Through Entrusting States Act (or STATES Act), a bill
that seeks protections for businesses and individuals in states
that have legalized and comply with state laws).
Notably with respect to our business, on November 1, 2019,
Colorado Bill HB-19-1090, was passed and made effective. This law
allows publicly traded corporations to apply for and qualify for
the ownership of Colorado cannabis licenses. Other states that have
legalized cannabis for recreational and/or medicinal use restrict
public companies from owning interests in state cannabis licenses
altogether, or have enacted regulations which make it difficult for
corporations to comply with application requirements, including all
shareholders submitting to and passing background checks.
On September 18, 2020, Colorado’s Marijuana Enforcement Division
(MED), approved the Company’s application for suitability,
establishing the Company as one of the few publicly traded
companies authorized to acquire and operate various cannabis
licenses throughout Colorado, in both the recreational and medical
markets.
American Cannabis (CE) (USOTC:AMMJ)
過去 株価チャート
から 12 2024 まで 1 2025
American Cannabis (CE) (USOTC:AMMJ)
過去 株価チャート
から 1 2024 まで 1 2025
